Stocks in Play: Oncolytics Biotech Inc
Announced translational data in heavily pretreated relapsed/refractory multiple myeloma patients, which will be presented at the 68th American Society of Hematology Annual Meeting and Exposition. Oncolytics ...
Eupraxia Pharmaceuticals Inc. "OUTPERFORM"
Analysts at RBC initiated coverage of Eupraxia Pharmaceuticals Inc. with an "OUTPERFORM" rating and a target of $14
Last Updated:
Analyst Ratings
Analysts at RBC initiated coverage of Eupraxia Pharmaceuticals Inc. with an "OUTPERFORM" rating and a target of $14
Crypto News
Research Reports
Edison Investment Research
Materialise
Edison Investment Research
Wheaton Precious Metals
Rockstone Research
Homerun Resources Inc.
Most Popular
Latest News
Stocks in Play: Quantum Secure Encryption Corp 53 mStocks in Play: Oncolytics Biotech Inc 1 h
Eupraxia Pharmaceuticals Inc. "OUTPERFORM" 1 h
Stocks in Play: Solaris Resources Inc. 1 h
Aon Climbs on Declaring Trophy Winner 1 h
Planet Labs Surges on Hookup with Stoke Space 1 h
Keysight Jumps on Winning ADS Designation 1 h
Cineplex, Greenfire, High Liner at 52-Week Highs on News 2 h
ETFs
Forex Daily Briefing
More from BayStreet
Full calendar- IVEY Purchasing Managers Index: 10:00am11/6/2026
- Labour Force Survey: 8:30am 11/6/2026
- TSX New Listing: Fireweed Metals Corp. 11/5/2026
- Canadian International Merchandise Trade: 8:30am 11/4/2026
- TSX New Listing: Maritime Launch Services Inc. 11/3/2026
- TSX New Listing: Purpose Active Equity Fund 11/3/2026